Erenumab
Category: Migraine / Tension HeadacheErenumab Overview
Erenumab, sold under the brand name Aimovig, is a medication which targets the calcitonin gene-related peptide receptor (CGRPR) for the prevention of migraine.[2][3][4] It was the first of the group of CGRPR antagonists to be FDA approved in 2018.[5] It is a form of monoclonal antibody therapy in which antibodies are used to block the receptors for the protein CGRP, thought to play a major role in starting migraines.[6&am...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Erenumab
Recent Erenumab Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Erenumab
- Injection: 70mg/ml
Other drugs which contain Erenumab or a similar ingredient: (1 result)
- AIMOVIG Erenumab-aooe